Foundayo Vs Zepbound, Wegovy, Rybelsus: Cost, Insurance, Side Effects

Key Points:

• The FDA approved Eli Lilly's new weight loss pill, Foundayo, on April 1, which can be taken at any time without food or water restrictions and is intended for adults with obesity or weight-related health conditions.
• Foundayo, containing orforglipron, has shown greater weight loss results compared to Novo Nordisk's oral GLP-1 drugs in trials, with patients losing up to 27 pounds on the highest dose.
• Insurance coverage for Foundayo varies widely, with many private plans and government programs often limiting coverage to type 2 diabetes patients, while Medicare Part D may offer coverage starting July 1, though details are pending.
• Foundayo's highest dose costs $349, higher than oral Wegovy's $299, but lower doses may be accessible for $25 with insurance and savings cards; Eli Lilly is promoting direct-to-consumer sales through partnerships with Walmart, Amazon, and telehealth providers.
• Common side effects of Foundayo include gastrointestinal issues and fatigue, with some patients experiencing more side effects than with similar drugs; long-term effects are still under study as GLP-1 medications expand in use and insurance coverage debates continue.